Jazz Pharmaceuticals plc (JAZZ)
USD 104.19
(0.78%)
USD 104.19
(0.78%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.83 Billion USD | 4.78% |
| 2022 | 3.65 Billion USD | 18.26% |
| 2021 | 3.09 Billion USD | 30.91% |
| 2020 | 2.36 Billion USD | 9.34% |
| 2019 | 2.16 Billion USD | 14.32% |
| 2018 | 1.89 Billion USD | 16.82% |
| 2017 | 1.61 Billion USD | 8.79% |
| 2016 | 1.48 Billion USD | 12.32% |
| 2015 | 1.32 Billion USD | 12.95% |
| 2014 | 1.17 Billion USD | 34.44% |
| 2013 | 872.42 Million USD | 48.88% |
| 2012 | 585.97 Million USD | 115.21% |
| 2011 | 272.27 Million USD | 56.68% |
| 2010 | 173.78 Million USD | 35.29% |
| 2009 | 128.44 Million USD | 90.26% |
| 2008 | 67.51 Million USD | 3.39% |
| 2007 | 65.3 Million USD | 45.58% |
| 2006 | 44.85 Million USD | 109.2% |
| 2005 | 21.44 Million USD | 0.0% |
| 2004 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 901.98 Million USD | -10.87% |
| 2024 Q2 | 1.02 Billion USD | 13.51% |
| 2023 Q2 | 957.31 Million USD | 7.22% |
| 2023 FY | 3.83 Billion USD | 4.78% |
| 2023 Q4 | 1.01 Billion USD | 4.09% |
| 2023 Q3 | 972.14 Million USD | 1.55% |
| 2023 Q1 | 892.81 Million USD | -8.16% |
| 2022 Q2 | 932.87 Million USD | 14.64% |
| 2022 Q1 | 813.72 Million USD | -9.26% |
| 2022 FY | 3.65 Billion USD | 18.26% |
| 2022 Q4 | 972.12 Million USD | 3.35% |
| 2022 Q3 | 940.65 Million USD | 0.83% |
| 2021 Q3 | 838.11 Million USD | 11.48% |
| 2021 Q1 | 607.58 Million USD | -8.71% |
| 2021 Q2 | 751.81 Million USD | 23.74% |
| 2021 Q4 | 896.73 Million USD | 6.99% |
| 2021 FY | 3.09 Billion USD | 30.91% |
| 2020 Q3 | 600.88 Million USD | 6.84% |
| 2020 FY | 2.36 Billion USD | 9.34% |
| 2020 Q4 | 665.51 Million USD | 10.76% |
| 2020 Q1 | 534.72 Million USD | -8.08% |
| 2020 Q2 | 562.43 Million USD | 5.18% |
| 2019 FY | 2.16 Billion USD | 14.32% |
| 2019 Q2 | 534.13 Million USD | 5.11% |
| 2019 Q3 | 537.7 Million USD | 0.67% |
| 2019 Q4 | 581.74 Million USD | 8.19% |
| 2019 Q1 | 508.18 Million USD | 6.66% |
| 2018 FY | 1.89 Billion USD | 16.82% |
| 2018 Q4 | 476.45 Million USD | 1.51% |
| 2018 Q3 | 469.37 Million USD | -6.22% |
| 2018 Q2 | 500.47 Million USD | 12.57% |
| 2018 Q1 | 444.61 Million USD | 1.88% |
| 2017 Q1 | 376.05 Million USD | -5.19% |
| 2017 FY | 1.61 Billion USD | 8.79% |
| 2017 Q4 | 436.39 Million USD | 5.96% |
| 2017 Q3 | 411.85 Million USD | 4.43% |
| 2017 Q2 | 394.38 Million USD | 4.88% |
| 2016 FY | 1.48 Billion USD | 12.32% |
| 2016 Q1 | 336.01 Million USD | -1.43% |
| 2016 Q4 | 396.62 Million USD | 6.0% |
| 2016 Q3 | 374.18 Million USD | -1.83% |
| 2016 Q2 | 381.16 Million USD | 13.44% |
| 2015 Q3 | 340.87 Million USD | 2.13% |
| 2015 FY | 1.32 Billion USD | 12.95% |
| 2015 Q1 | 309.3 Million USD | -5.74% |
| 2015 Q2 | 333.74 Million USD | 7.9% |
| 2015 Q4 | 340.88 Million USD | 0.0% |
| 2014 Q2 | 291.23 Million USD | 17.95% |
| 2014 FY | 1.17 Billion USD | 34.44% |
| 2014 Q1 | 246.91 Million USD | 4.73% |
| 2014 Q4 | 328.14 Million USD | 7.03% |
| 2014 Q3 | 306.58 Million USD | 5.27% |
| 2013 Q4 | 235.77 Million USD | 1.56% |
| 2013 FY | 872.42 Million USD | 48.88% |
| 2013 Q2 | 208.25 Million USD | 6.12% |
| 2013 Q1 | 196.23 Million USD | 6.82% |
| 2013 Q3 | 232.16 Million USD | 11.48% |
| 2012 Q2 | 129.53 Million USD | 19.49% |
| 2012 FY | 585.97 Million USD | 115.21% |
| 2012 Q1 | 108.41 Million USD | 29.78% |
| 2012 Q4 | 183.7 Million USD | 4.67% |
| 2012 Q3 | 175.51 Million USD | 35.49% |
| 2011 Q1 | 50.88 Million USD | -4.66% |
| 2011 Q2 | 64.56 Million USD | 26.9% |
| 2011 Q3 | 73.29 Million USD | 13.51% |
| 2011 Q4 | 83.53 Million USD | 13.98% |
| 2011 FY | 272.27 Million USD | 56.68% |
| 2010 FY | 173.78 Million USD | 35.29% |
| 2010 Q2 | 40.48 Million USD | 15.11% |
| 2010 Q1 | 35.17 Million USD | -8.13% |
| 2010 Q4 | 53.36 Million USD | 19.25% |
| 2010 Q3 | 44.75 Million USD | 10.54% |
| 2009 Q3 | 30.8 Million USD | -17.36% |
| 2009 Q4 | 38.28 Million USD | 24.26% |
| 2009 FY | 128.44 Million USD | 90.26% |
| 2009 Q2 | 37.28 Million USD | 68.87% |
| 2009 Q1 | 22.07 Million USD | 12.66% |
| 2008 Q3 | 17.74 Million USD | 14.2% |
| 2008 Q4 | 19.59 Million USD | 10.42% |
| 2008 Q1 | 14.63 Million USD | -5.45% |
| 2008 Q2 | 15.53 Million USD | 6.18% |
| 2008 FY | 67.51 Million USD | 3.39% |
| 2007 Q1 | 14.08 Million USD | 20.69% |
| 2007 Q4 | 15.47 Million USD | -27.93% |
| 2007 Q2 | 14.26 Million USD | 1.25% |
| 2007 Q3 | 21.47 Million USD | 50.55% |
| 2007 FY | 65.3 Million USD | 45.58% |
| 2006 Q4 | 11.67 Million USD | 0.0% |
| 2006 FY | 44.85 Million USD | 109.2% |
| 2006 Q1 | 9.83 Million USD | 83.53% |
| 2006 Q2 | 11.67 Million USD | 18.66% |
| 2006 Q3 | 11.67 Million USD | 0.0% |
| 2005 Q4 | 5.36 Million USD | -0.02% |
| 2005 Q2 | 5.36 Million USD | 0.0% |
| 2005 FY | 21.44 Million USD | 0.0% |
| 2005 Q1 | 5.36 Million USD | 0.0% |
| 2005 Q3 | 5.36 Million USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AnaptysBio, Inc. | 17.15 Million USD | -22247.753% |
| BioXcel Therapeutics, Inc. | 1.38 Million USD | -277740.87% |
| Akebia Therapeutics, Inc. | 194.62 Million USD | -1870.067% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | -109.715% |
| Fortress Biotech, Inc. | 84.51 Million USD | -4436.822% |
| Fortress Biotech, Inc. | 84.51 Million USD | -4436.822% |
| GlycoMimetics, Inc. | 10 Thousand USD | -38341940.0% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 832.01 Thousand USD | -460736.288% |
| Keros Therapeutics, Inc. | 151 Thousand USD | -2539107.947% |
| Ligand Pharmaceuticals Incorporated | 131.31 Million USD | -2819.874% |
| MiMedx Group, Inc. | 321.47 Million USD | -1092.684% |
| MEI Pharma, Inc. | 65.29 Million USD | -5771.945% |
| Mersana Therapeutics, Inc. | 36.85 Million USD | -10303.484% |
| IO Biotech, Inc. | - USD | -Infinity% |
| NextCure, Inc. | - USD | -Infinity% |
| Opthea Limited | 261.85 Thousand USD | -1464124.64% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| PDS Biotechnology Corporation | - USD | -Infinity% |
| Precigen, Inc. | 6.22 Million USD | -61493.639% |
| Syndax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pyxis Oncology, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Seer, Inc. | 15.18 Million USD | -25154.933% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | -2075.657% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | - USD | -Infinity% |
| Senti Biosciences, Inc. | 2.56 Million USD | -149615.111% |
| Acelyrin, Inc. | - USD | -Infinity% |
| TG Therapeutics, Inc. | 233.66 Million USD | -1540.919% |
| Wave Life Sciences Ltd. | 113.3 Million USD | -3283.967% |
| Xeris Biopharma Holdings, Inc. | 163.91 Million USD | -2239.156% |
| HOOKIPA Pharma Inc. | 20.12 Million USD | -18948.159% |
| Eton Pharmaceuticals, Inc. | 31.64 Million USD | -12017.451% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| AlloVir, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 33.87 Million USD | -11217.347% |
| Onconetix, Inc. | 58.46 Thousand USD | -6558018.532% |
| Pieris Pharmaceuticals, Inc. | 42.81 Million USD | -8856.328% |
| Phathom Pharmaceuticals, Inc. | 682 Thousand USD | -562100.0% |
| Syros Pharmaceuticals, Inc. | 9.93 Million USD | -38489.01% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -115041.261% |
| Rigel Pharmaceuticals, Inc. | 116.88 Million USD | -3180.406% |
| Madrigal Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dyadic International, Inc. | 2.89 Million USD | -132168.389% |
| Jaguar Health, Inc. | 9.76 Million USD | -39180.852% |
| Lantern Pharma Inc. | - USD | -Infinity% |
| VistaGen Therapeutics, Inc. | 1.06 Million USD | -360257.519% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 57.3 Million USD | -6590.755% |
| Sorrento Therapeutics, Inc. | 62.83 Million USD | -6001.631% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 24.35 Million USD | -15643.631% |
| Agenus Inc. | 156.31 Million USD | -2352.886% |
| Royalty Pharma plc | 2.35 Billion USD | -62.842% |
| Bicycle Therapeutics plc | 26.97 Million USD | -14113.39% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 63.53 Million USD | -5934.98% |
| IDEAYA Biosciences, Inc. | 23.38 Million USD | -16295.997% |
| TRACON Pharmaceuticals, Inc. | 12.04 Million USD | -31732.329% |
| Vaxxinity, Inc. | - USD | -Infinity% |
| C4 Therapeutics, Inc. | 20.75 Million USD | -18372.75% |
| Oncternal Therapeutics, Inc. | 785 Thousand USD | -488333.631% |
| Clearside Biomedical, Inc. | 8.22 Million USD | -46510.795% |
| CRISPR Therapeutics AG | 371.2 Million USD | -932.905% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| Incyte Corporation | 3.69 Billion USD | -3.749% |
| Janux Therapeutics, Inc. | 8.08 Million USD | -47335.408% |
| ContextLogic Inc. | 287 Million USD | -1235.96% |
| Inhibrx Biosciences, Inc. | 1.8 Million USD | -212911.333% |
| Verrica Pharmaceuticals Inc. | 5.12 Million USD | -74728.337% |
| Aptorum Group Limited | 431.37 Thousand USD | -888726.968% |
| Ardelyx, Inc. | 124.45 Million USD | -2980.771% |
| Pharming Group N.V. | 245.31 Million USD | -1462.965% |
| Chimerix, Inc. | 324 Thousand USD | -1183296.296% |
| ChromaDex Corporation | 83.57 Million USD | -4488.015% |
| CARGO Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Caribou Biosciences, Inc. | 34.47 Million USD | -11021.049% |
| TransCode Therapeutics, Inc. | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 129.01 Million USD | -2871.952% |
| Sol-Gel Technologies Ltd. | 1.55 Million USD | -246631.274% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Structure Therapeutics Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -477980.299% |
| Intensity Therapeutics, Inc. | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 184 Thousand USD | -2083706.522% |
| AbCellera Biologics Inc. | 38.02 Million USD | -9983.377% |
| Alkermes plc | 1.66 Billion USD | -130.503% |
| Orchestra BioMed Holdings, Inc. | 2.76 Million USD | -138820.435% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -20028.112% |
| Avidity Biosciences, Inc. | 9.56 Million USD | -40006.736% |
| Geron Corporation | 237 Thousand USD | -1617707.595% |
| Summit Therapeutics Inc. | - USD | -Infinity% |
| Stoke Therapeutics, Inc. | 8.78 Million USD | -43569.749% |
| Alaunos Therapeutics, Inc. | 5000.00 USD | -76683980.0% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| Inhibikase Therapeutics, Inc. | 260.5 Thousand USD | -1471763.34% |
| Innoviva, Inc. | 310.46 Million USD | -1134.995% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 30.98 Million USD | -12272.79% |
| Vaxcyte, Inc. | - USD | -Infinity% |
| ADMA Biologics, Inc. | 258.21 Million USD | -1384.888% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -1492.707% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -904193.396% |
| Novavax, Inc. | 983.7 Million USD | -289.772% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Compass Therapeutics, Inc. | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 398.2 Million USD | -862.874% |
| Precision BioSciences, Inc. | 48.72 Million USD | -7768.746% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| ImmuCell Corporation | 17.47 Million USD | -21845.265% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Mesoblast Limited | 5.9 Million USD | -64864.487% |
| Rocket Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptose Biosciences Inc. | - USD | -Infinity% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 839.35 Thousand USD | -456701.44% |
| Century Therapeutics, Inc. | 2.23 Million USD | -171452.752% |
| Kura Oncology, Inc. | - USD | -Infinity% |
| TScan Therapeutics, Inc. | 21.04 Million USD | -18115.611% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 101.21 Million USD | -3688.215% |
| Autolus Therapeutics plc | 1.69 Million USD | -225707.067% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 46.01 Million USD | -8231.966% |
| Eterna Therapeutics Inc. | 68 Thousand USD | -5638435.294% |
| Adaptive Biotechnologies Corporation | 170.27 Million USD | -2151.758% |
| GRI Bio, Inc. | 21.76 Million USD | -17514.756% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -150853.745% |
| Tenaya Therapeutics, Inc. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 2.13 Million USD | -179909.577% |
| INmune Bio, Inc. | 155 Thousand USD | -2473580.0% |
| Heron Therapeutics, Inc. | 127.04 Million USD | -2918.013% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -171146.959% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | - USD | -Infinity% |
| Milestone Pharmaceuticals Inc. | 1 Million USD | -383320.4% |
| X4 Pharmaceuticals, Inc. | - USD | -Infinity% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -44624.181% |
| Coherus BioSciences, Inc. | 257.24 Million USD | -1390.493% |
| Verastem, Inc. | - USD | -Infinity% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -109448.686% |
| Pliant Therapeutics, Inc. | 1.58 Million USD | -242571.139% |
| Tonix Pharmaceuticals Holding Corp. | 7.76 Million USD | -49258.96% |
| Histogen Inc. | 3.76 Million USD | -101630.008% |
| Aprea Therapeutics, Inc. | 583.23 Thousand USD | -657307.442% |
| Surrozen, Inc. | - USD | -Infinity% |
| Organovo Holdings, Inc. | 109 Thousand USD | -3517518.349% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 391.69 Thousand USD | -978774.89% |
| Panbela Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.85 Million USD | -55849.278% |
| Hepion Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arcturus Therapeutics Holdings Inc. | 157.74 Million USD | -2330.588% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -2629669.547% |
| Apollomics, Inc. | 821 Thousand USD | -466916.322% |
| Amarin Corporation plc | 306.91 Million USD | -1149.289% |
| Turnstone Biologics Corp. | 19.3 Million USD | -19760.168% |
| Kymera Therapeutics, Inc. | 78.59 Million USD | -4778.619% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | - USD | -Infinity% |
| Aurinia Pharmaceuticals Inc. | 175.51 Million USD | -2084.57% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.83 Billion USD | -109.496% |
| Better Therapeutics, Inc. | - USD | -Infinity% |
| Nurix Therapeutics, Inc. | 76.98 Million USD | -4880.327% |
| Apellis Pharmaceuticals, Inc. | 396.59 Million USD | -866.79% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 1.33 Million USD | -287969.421% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 139.91 Million USD | -2640.459% |
| Insmed Incorporated | 305.2 Million USD | -1156.259% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 18.68 Million USD | -20419.127% |
| OmniAb, Inc. | 34.16 Million USD | -11122.936% |
| Alector, Inc. | 97.06 Million USD | -3850.263% |
| Seres Therapeutics, Inc. | 126.32 Million USD | -2935.19% |
| Checkpoint Therapeutics, Inc. | 103 Thousand USD | -3722428.155% |
| Zai Lab Limited | 266.71 Million USD | -1337.544% |
| Revance Therapeutics, Inc. | 234.04 Million USD | -1538.269% |
| Aura Biosciences, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -2949287.692% |
| Immunic, Inc. | - USD | -Infinity% |
| Tarsus Pharmaceuticals, Inc. | 17.44 Million USD | -21876.294% |
| Veracyte, Inc. | 361.05 Million USD | -961.956% |
| InMed Pharmaceuticals Inc. | 4.59 Million USD | -83293.414% |
| FibroGen, Inc. | 147.75 Million USD | -2495.027% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 147.8 Thousand USD | -2593996.275% |
| Cyclacel Pharmaceuticals, Inc. | 420 Thousand USD | -912805.714% |
| Amylyx Pharmaceuticals, Inc. | 380.78 Million USD | -906.918% |
| Galecto, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | - USD | -Infinity% |
| Fortrea Holdings Inc. | 3.1 Billion USD | -23.326% |
| KalVista Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptevo Therapeutics Inc. | - USD | -Infinity% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 1.55 Million USD | -245997.818% |
| Foghorn Therapeutics Inc. | 34.15 Million USD | -11125.894% |
| Y-mAbs Therapeutics, Inc. | 84.81 Million USD | -4420.454% |
| Theravance Biopharma, Inc. | 57.42 Million USD | -6577.006% |
| Ultragenyx Pharmaceutical Inc. | 434.24 Million USD | -782.951% |
| Metagenomi, Inc. Common Stock | 44.75 Million USD | -8466.905% |
| BioCryst Pharmaceuticals, Inc. | 331.41 Million USD | -1056.93% |
| Gain Therapeutics, Inc. | 55.18 Thousand USD | -6948439.326% |
| Cartesian Therapeutics, Inc. | 26 Million USD | -14644.67% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | 9000.00 USD | -42602166.667% |
| Marker Therapeutics, Inc. | 3.31 Million USD | -115697.342% |
| Regeneron Pharmaceuticals, Inc. | 13.11 Billion USD | 70.77% |
| Chemomab Therapeutics Ltd. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 122.11 Thousand USD | -3139807.626% |
| Pluri Inc. | 326 Thousand USD | -1176036.196% |
| Prothena Corporation plc | 91.37 Million USD | -4096.349% |
| Adaptimmune Therapeutics plc | 60.28 Million USD | -6260.551% |
| Celularity Inc. | 22.77 Million USD | -16738.101% |
| Rallybio Corporation | - USD | -Infinity% |
| Cue Biopharma, Inc. | 5.49 Million USD | -69739.781% |
| MeiraGTx Holdings plc | 14.01 Million USD | -27253.956% |
| Omeros Corporation | - USD | -Infinity% |
| Humacyte, Inc. | - USD | -Infinity% |
| Immunocore Holdings plc | 249.42 Million USD | -1437.199% |
| Cocrystal Pharma, Inc. | - USD | -Infinity% |
| Cidara Therapeutics, Inc. | 63.9 Million USD | -5899.85% |
| Blueprint Medicines Corporation | 249.38 Million USD | -1437.495% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | - USD | -Infinity% |
| Sana Biotechnology, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 7.29 Million USD | -52437.736% |
| Elicio Therapeutics, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -10469.825% |
| Adlai Nortye Ltd. American Depositary Shares | 4.99 Million USD | -76650.807% |
| Cytokinetics, Incorporated | 7.53 Million USD | -50819.044% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -183766.986% |
| Protara Therapeutics, Inc. | - USD | -Infinity% |
| Vor Biopharma Inc. | - USD | -Infinity% |
| Roivant Sciences Ltd. | 124.79 Million USD | -2972.402% |
| Evogene Ltd. | 5.64 Million USD | -67882.34% |
| ProKidney Corp. | - USD | -Infinity% |
| Applied Therapeutics, Inc. | 9.99 Million USD | -38268.898% |
| BridgeBio Pharma, Inc. | 9.3 Million USD | -41114.705% |
| CorMedix Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 4.8 Million USD | -79779.25% |
| Tango Therapeutics, Inc. | 36.52 Million USD | -10396.904% |
| Galectin Therapeutics Inc. | - USD | -Infinity% |
| Atai Life Sciences N.V. | 314 Thousand USD | -1220984.076% |
| Renovaro Biosciences Inc. | - USD | -Infinity% |
| Aerovate Therapeutics, Inc. | - USD | -Infinity% |
| Zentalis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sagimet Biosciences Inc. | 2 Million USD | -191610.2% |
| MediciNova, Inc. | 1 Million USD | -383320.4% |
| Praxis Precision Medicines, Inc. | 2.44 Million USD | -156589.988% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -22468133.226% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | -1316.927% |
| Biomea Fusion, Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 937.82 Million USD | -308.841% |
| Mereo BioPharma Group plc | 10 Million USD | -38242.04% |
| Cullinan Oncology, Inc. | - USD | -Infinity% |
| Absci Corporation | 5.71 Million USD | -66954.984% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 20.72 Million USD | -18402.167% |
| Dyne Therapeutics, Inc. | - USD | -Infinity% |
| Kiniksa Pharmaceuticals, Ltd. | 270.25 Million USD | -1318.715% |
| Ventyx Biosciences, Inc. | - USD | -Infinity% |
| Allakos Inc. | - USD | -Infinity% |
| Imunon, Inc. | - USD | -Infinity% |
| Fulcrum Therapeutics, Inc. | 2.8 Million USD | -136591.765% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | -694.86% |
| BioAtla, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | - USD | -Infinity% |
| Allogene Therapeutics, Inc. | 95 Thousand USD | -4035904.211% |
| Larimar Therapeutics, Inc. | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -80484.363% |
| Kezar Life Sciences, Inc. | 7 Million USD | -54674.343% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -18185.979% |
| aTyr Pharma, Inc. | 353 Thousand USD | -1086076.771% |
| Aligos Therapeutics, Inc. | 15.52 Million USD | -24590.605% |
| Akero Therapeutics, Inc. | - USD | -Infinity% |
| Viridian Therapeutics, Inc. | 314 Thousand USD | -1220984.076% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 12.05 Thousand USD | -31795272.751% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | -362.368% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -1694890.451% |
| UroGen Pharma Ltd. | 82.71 Million USD | -4535.552% |
| Sutro Biopharma, Inc. | 153.73 Million USD | -2394.099% |
| ZIVO Bioscience, Inc. | 27.65 Thousand USD | -13866822.242% |
| Orgenesis Inc. | 530 Thousand USD | -723334.717% |
| Entera Bio Ltd. | - USD | -Infinity% |
| GH Research PLC | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | - USD | -Infinity% |
| Reneo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 168.33 Million USD | -2177.682% |
| 60 Degrees Pharmaceuticals, Inc. | 253.57 Thousand USD | -1511971.08% |
| Replimune Group, Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 192.64 Million USD | -1890.347% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -1694890.451% |
| Portage Biotech Inc. | - USD | -Infinity% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -22468133.226% |
| Olema Pharmaceuticals, Inc. | - USD | -Infinity% |
| OncoCyte Corporation | 1.5 Million USD | -255003.393% |
| Qualigen Therapeutics, Inc. | 5.2 Million USD | -73567.329% |
| Processa Pharmaceuticals, Inc. | - USD | -Infinity% |
| Purple Biotech Ltd. | - USD | -Infinity% |
| CollPlant Biotechnologies Ltd. | 10.95 Million USD | -34886.805% |
| scPharmaceuticals Inc. | 13.59 Million USD | -28107.195% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | - USD | -Infinity% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | - USD | -Infinity% |
| Curis, Inc. | 10.02 Million USD | -38154.056% |
| Daré Bioscience, Inc. | 2.8 Million USD | -136451.319% |
| Carmell Therapeutics Corporation | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | - USD | -Infinity% |
| BeiGene, Ltd. | 2.45 Billion USD | -55.939% |
| Kiromic BioPharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. Warrant | 11.58 Million USD | -33010.57% |
| Protagonist Therapeutics, Inc. | 60 Million USD | -6290.34% |
| Erasca, Inc. | - USD | -Infinity% |
| bluebird bio, Inc. | 29.49 Million USD | -12898.624% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | -58.489% |
| DBV Technologies S.A. | 15.72 Million USD | -24278.204% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | 6.84 Billion USD | 44.01% |
| Vincerx Pharma, Inc. | - USD | -Infinity% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -47791.631% |
| Acrivon Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 145.23 Million USD | -2539.945% |
| Monte Rosa Therapeutics, Inc. | - USD | -Infinity% |
| Spruce Biosciences, Inc. | 10.08 Million USD | -37903.806% |
| Celldex Therapeutics, Inc. | 6.88 Million USD | -55605.419% |
| Cogent Biosciences, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 58.74 Million USD | -6426.416% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | - USD | -Infinity% |
| Aditxt, Inc. | 645.17 Thousand USD | -594188.07% |
| Adagene Inc. | 18.11 Million USD | -21070.007% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -354262.662% |
| Maravai LifeSciences Holdings, Inc. | 288.94 Million USD | -1226.967% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 250 Million USD | -1433.633% |
| SciSparc Ltd. | 2.87 Million USD | -133078.326% |
| Vericel Corporation | 197.51 Million USD | -1841.212% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 5.9 Million USD | -64842.48% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 59.6 Million USD | -6332.581% |
| Invivyd, Inc. | - USD | -Infinity% |
| Relay Therapeutics, Inc. | 25.54 Million USD | -14909.019% |
| Quoin Pharmaceuticals, Ltd. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.73 Million USD | -3863.616% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 100.38 Million USD | -3719.423% |
| Clene Inc. | 654 Thousand USD | -586169.725% |
| Capricor Therapeutics, Inc. | 25.17 Million USD | -15128.35% |
| Boundless Bio, Inc. Common Stock | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 44.57 Million USD | -8501.692% |
| Citius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Contineum Therapeutics, Inc. Class A Common Stock | 50 Million USD | -7568.408% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 107 Thousand USD | -3583268.224% |
| ALX Oncology Holdings Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 86.18 Million USD | -4349.065% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -5244188.215% |
| Ocular Therapeutix, Inc. | 58.44 Million USD | -6460.587% |
| Verve Therapeutics, Inc. | 11.75 Million USD | -32509.321% |
| Trevena, Inc. | 3.12 Million USD | -122594.528% |
| Surrozen, Inc. | - USD | -Infinity% |
| Tyra Biosciences, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 726.43 Million USD | -427.81% |
| Connect Biopharma Holdings Limited | - USD | -Infinity% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 6.28 Million USD | -60876.527% |
| Bolt Biotherapeutics, Inc. | 7.87 Million USD | -48582.123% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Statera Biopharma, Inc. | - USD | -Infinity% |
| ImmunityBio, Inc. | 622 Thousand USD | -616331.511% |
| Korro Bio, Inc. | - USD | -Infinity% |
| Kineta, Inc. | 5.44 Million USD | -70355.788% |
| BioVie Inc. | - USD | -Infinity% |
| Codexis, Inc. | 70.14 Million USD | -5366.267% |
| Celularity Inc. | 22.77 Million USD | -16738.101% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -95444.58% |
| Celcuity Inc. | - USD | -Infinity% |
| Virax Biolabs Group Limited | 156.41 Thousand USD | -2451139.3% |
| Cibus, Inc. | 1.81 Million USD | -210918.382% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | - USD | -Infinity% |
| Annexon, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 3.6 Million USD | -106405.667% |
| Assembly Biosciences, Inc. | 7.16 Million USD | -53427.907% |
| Avalo Therapeutics, Inc. | 1.92 Million USD | -199182.952% |
| Ionis Pharmaceuticals, Inc. | 787.64 Million USD | -386.792% |
| Eyenovia, Inc. | 3787.00 USD | -101246374.782% |
| Puma Biotechnology, Inc. | 235.63 Million USD | -1527.166% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | - USD | -Infinity% |
| Arcellx, Inc. | 110.31 Million USD | -3375.561% |
| Cardiff Oncology, Inc. | 488 Thousand USD | -785597.541% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -4740.922% |
| Regulus Therapeutics Inc. | - USD | -Infinity% |
| Moolec Science SA | 905.04 Thousand USD | -423546.013% |
| Acumen Pharmaceuticals, Inc. | - USD | -Infinity% |
| LAVA Therapeutics N.V. | 6.76 Million USD | -56543.581% |
| Atea Pharmaceuticals, Inc. | - USD | -Infinity% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 733.87 Thousand USD | -522362.94% |
| Humacyte, Inc. | - USD | -Infinity% |
| 89bio, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 170 Thousand USD | -2255314.118% |
| Trevi Therapeutics, Inc. | - USD | -Infinity% |
| Lexicon Pharmaceuticals, Inc. | 1.2 Million USD | -318355.482% |
| Notable Labs, Ltd. | 310 Thousand USD | -1236740.0% |
| Liquidia Corporation | 17.48 Million USD | -21824.771% |
| Mustang Bio, Inc. | - USD | -Infinity% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -354262.662% |
| Arbutus Biopharma Corporation | 18.14 Million USD | -21035.571% |
| DiaMedica Therapeutics Inc. | - USD | -Infinity% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -205818.582% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 1.71 Million USD | -223782.704% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | - USD | -Infinity% |
| PepGen Inc. | - USD | -Infinity% |
| Moleculin Biotech, Inc. | - USD | -Infinity% |
| United Therapeutics Corporation | 2.32 Billion USD | -64.735% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 72.1 Thousand USD | -5317649.854% |
| Belite Bio, Inc | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -80484.363% |
| ARS Pharmaceuticals, Inc. | 30 Thousand USD | -12780580.0% |
| Bionomics Limited | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -24101.25% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 64.7 Million USD | -5825.852% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | - USD | -Infinity% |
| Altimmune, Inc. | 426 Thousand USD | -899947.887% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | -860.097% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| Compugen Ltd. | 33.45 Million USD | -11359.41% |
| Peak Bio, Inc. | 367.87 Thousand USD | -1042151.622% |
| Zevra Therapeutics, Inc. | 27.46 Million USD | -13862.361% |
| Benitec Biopharma Inc. | 216 Thousand USD | -1774994.444% |
| Spyre Therapeutics, Inc. | 886 Thousand USD | -432654.402% |
| NKGen Biotech, Inc. Common Stock | - USD | -Infinity% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | - USD | -Infinity% |
| Aileron Therapeutics, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | - USD | -Infinity% |
| Instil Bio, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | -212.66% |
| Immunome, Inc. | 14.01 Million USD | -27252.005% |
| Verona Pharma plc | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | - USD | -Infinity% |
| Shattuck Labs, Inc. | 1.65 Million USD | -231294.327% |
| CervoMed Inc. | 7.14 Million USD | -53563.719% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.91 Million USD | -77942.011% |
| Dianthus Therapeutics, Inc. | 2.82 Million USD | -135576.008% |
| Moolec Science SA | 905.04 Thousand USD | -423546.013% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | - USD | -Infinity% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 2.46 Million USD | -155758.847% |
| Seelos Therapeutics, Inc. | 2.2 Million USD | -173944.666% |
| Lumos Pharma, Inc. | 2.05 Million USD | -186843.15% |
| Achilles Therapeutics plc | - USD | -Infinity% |
| enGene Holdings Inc. Common Stock | - USD | -Infinity% |
| 180 Life Sciences Corp. | - USD | -Infinity% |
| Opiant Pharmaceuticals, Inc. | 40.72 Million USD | -9314.823% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -183766.986% |
| ORIC Pharmaceuticals, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 204 Thousand USD | -1879411.765% |
| Fractyl Health, Inc. Common Stock | 120 Thousand USD | -3195070.0% |
| Rani Therapeutics Holdings, Inc. | - USD | -Infinity% |
| MoonLake Immunotherapeutics | - USD | -Infinity% |
| Palisade Bio, Inc. | 250 Thousand USD | -1533581.6% |
| Tourmaline Bio, Inc. | - USD | -Infinity% |
| Beam Therapeutics Inc. | 377.7 Million USD | -915.121% |
| Neurogene Inc. | - USD | -Infinity% |
| Mirum Pharmaceuticals, Inc. | 186.37 Million USD | -1957.263% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -9485.51% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -322373.003% |
| Taysha Gene Therapies, Inc. | 15.45 Million USD | -24715.248% |
| Athira Pharma, Inc. | - USD | -Infinity% |
| Vaccinex, Inc. | 570 Thousand USD | -672567.368% |
| HCW Biologics Inc. | 2.84 Million USD | -134821.954% |
| XOMA Corporation | 4.75 Million USD | -80484.363% |
| Nektar Therapeutics | 90.12 Million USD | -4154.46% |
| Arvinas, Inc. | 78.5 Million USD | -4784.336% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | 43.94 Million USD | -8624.609% |
| Omega Therapeutics, Inc. | 3.09 Million USD | -123823.853% |
| Quince Therapeutics, Inc. | - USD | -Infinity% |
| Rezolute, Inc. | - USD | -Infinity% |
| Clene Inc. | 654 Thousand USD | -586169.725% |
| Indaptus Therapeutics, Inc. | - USD | -Infinity% |
| BeyondSpring Inc. | 1.75 Million USD | -218872.244% |
| Synlogic, Inc. | 3.37 Million USD | -113640.848% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -1042151.622% |
| Werewolf Therapeutics, Inc. | 19.94 Million USD | -19125.814% |
| Krystal Biotech, Inc. | 50.69 Million USD | -7462.682% |
| Karyopharm Therapeutics Inc. | 146.03 Million USD | -2525.574% |
| SpringWorks Therapeutics, Inc. | 5.44 Million USD | -70291.114% |
| Lipella Pharmaceuticals Inc. | 449.61 Thousand USD | -852671.136% |
| MannKind Corporation | 198.96 Million USD | -1827.104% |
| Ikena Oncology, Inc. | 9.16 Million USD | -41758.122% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 113.45 Million USD | -3279.642% |
| Gossamer Bio, Inc. | - USD | -Infinity% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 285.14 Million USD | -1244.66% |
| Mural Oncology plc | - USD | -Infinity% |
| Biora Therapeutics, Inc. | 4000.00 USD | -95855000.0% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | - USD | -Infinity% |
| Champions Oncology, Inc. | 50.15 Million USD | -7544.709% |
| REGENXBIO Inc. | 90.24 Million USD | -4148.802% |
| Ensysce Biosciences, Inc. | 2.23 Million USD | -171797.315% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | - USD | -Infinity% |
| Edgewise Therapeutics, Inc. | - USD | -Infinity% |
| Vaxart, Inc. | 7.37 Million USD | -51861.025% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | - USD | -Infinity% |
| Cellectis S.A. | 755 Thousand USD | -507741.589% |
| Longeveron Inc. | 709 Thousand USD | -540690.409% |
| Repare Therapeutics Inc. | 51.13 Million USD | -7398.492% |
| Sarepta Therapeutics, Inc. | 1.24 Billion USD | -208.38% |
| Inozyme Pharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. | 11.58 Million USD | -33010.57% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | - USD | -Infinity% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 210 Thousand USD | -1825711.429% |
| Vertex Pharmaceuticals Incorporated | 9.86 Billion USD | 61.15% |
| Denali Therapeutics Inc. | 330.53 Million USD | -1060.013% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 16.29 Million USD | -23427.115% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Passage Bio, Inc. | - USD | -Infinity% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | - USD | -Infinity% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -141749.945% |
| Scinai Immunotherapeutics Ltd. | - USD | -Infinity% |
| Rhythm Pharmaceuticals, Inc. | 77.42 Million USD | -4851.961% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 152.43 Thousand USD | -2515286.735% |
| Carisma Therapeutics, Inc. | 14.91 Million USD | -25600.141% |
| Unicycive Therapeutics, Inc. | 675 Thousand USD | -567930.222% |
| OmniAb, Inc. | 34.16 Million USD | -11122.936% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 21.25 Million USD | -17941.615% |
| Lipocine Inc. | -2.85 Million USD | 134594.871% |
| Lexeo Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Nautilus Biotechnology, Inc. | - USD | -Infinity% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -171146.959% |
| G1 Therapeutics, Inc. | 82.51 Million USD | -4546.9% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | 86.45 Million USD | -4334.913% |
| Ocugen, Inc. | 6.03 Million USD | -63422.266% |
| Mind Medicine (MindMed) Inc. | - USD | -Infinity% |
| Q32 Bio Inc. | 1.15 Million USD | -331578.547% |
| Brainstorm Cell Therapeutics Inc. | - USD | -Infinity% |
| Alumis Inc. Common Stock | - USD | -Infinity% |
| Equillium, Inc. | 36.08 Million USD | -10525.773% |
| Kyverna Therapeutics, Inc. | - USD | -Infinity% |
| Coya Therapeutics, Inc. | 6 Million USD | -63779.913% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | - USD | -Infinity% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 633.1 Thousand USD | -605521.843% |
| Dominari Holdings Inc. | 2.03 Million USD | -187943.355% |
| Edesa Biotech, Inc. | - USD | -Infinity% |
| vTv Therapeutics Inc. | - USD | -Infinity% |
| Bio-Techne Corporation | 1.15 Billion USD | -230.803% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -14194.464% |
| Harmony Biosciences Holdings, Inc. | 582.02 Million USD | -558.773% |
| Prelude Therapeutics Incorporated | - USD | -Infinity% |
| Candel Therapeutics, Inc. | - USD | -Infinity% |
| iTeos Therapeutics, Inc. | 12.59 Million USD | -30342.271% |
| Nkarta, Inc. | - USD | -Infinity% |
| BioCardia, Inc. | 477 Thousand USD | -803716.352% |
| Iterum Therapeutics plc | - USD | -Infinity% |